On May 27, 2021, Janet Woodcock — then Acting FDA Commissioner, with 37 years at the agency — sent an email to Anthony Fauci and NIH Director Francis Collins describing a cluster of symptoms showing up in vaccinated patients. Excessive fatigue. Brain fog. Difficulty concentrating. Exercise intolerance. Muscle aches. Numbness. Sleep problems. Tinnitus.
Fauci's response, revealed in newly surfaced documents: "We cannot ignore her. We should probably bring in CDC and see what Rochelle thinks."
That sounds almost reasonable — until you realize what happened next: Nothing.
Woodcock didn't send a vague hunch. She laid out a specific case. She warned that "the symptoms do not fit together into a distinctive syndrome" — meaning standard surveillance tools would miss them. She explicitly noted that "these problems are not the sort that a system like VAERS would be able to detect." The FDA's own BEST surveillance system wasn't built for this either. She was telling them, in plain English, that the existing safety net had holes and patients were falling through.
She even anticipated the pushback. "I doubt the industry would support, for obvious reasons," Woodcock wrote. Pharmaceutical companies weren't going to volunteer to study whether their product was hurting people. That's why she was asking NIAID — Fauci's shop, with its $5.5 billion annual research budget — to step in.
Her warning was blunt: "My experience is, that if you let a problem fester, then it will come back to bite you later."
Five years later, here we are. Bitten.
The study Woodcock requested never materialized under Fauci's watch. The most significant research we have is a Yale study examining post-vaccination syndrome — PVS — in a sample of just 42 people. Forty-two. That study found higher circulating SARS-CoV-2 spike protein in some PVS participants, which is exactly the kind of finding that should have triggered a massive follow-up. It didn't.
So what did Fauci actually do with Woodcock's email? He punted to Rochelle Walensky at the CDC. "See what Rochelle thinks" is government-speak for "make it someone else's problem." The man running a $5.5 billion research operation — the single largest infectious-disease research budget on the planet — decided the appropriate response to a documented safety concern from the Acting FDA Commissioner was a referral.
Senators Ron Johnson and Rand Paul have been hammering this point for years now. Johnson's hearings surfaced testimony from vaccine-injured patients that the mainstream press largely ignored. Paul grilled Fauci repeatedly on gain-of-function research and NIH transparency. They were called conspiracy theorists. Woodcock's email proves they were asking the right questions the whole time.
The usual defense — "we didn't know" — doesn't survive with this document. Woodcock told them. In writing. With specifics. She named the symptoms. She identified the surveillance gaps. She warned about the consequences of inaction. She even predicted the industry's resistance.
Fauci knew. He chose not to look.
There's a word for when a doctor suspects a patient might be harmed by a treatment and deliberately avoids confirming it. It isn't "following the science." Woodcock gave Fauci the professional courtesy of a private warning and a chance to get ahead of the problem. He gave her a cc to Rochelle Walensky and five years of silence.
That silence had a cost. It was measured in 42-person studies that should have been 42,000. In patients told their symptoms were anxiety. In a public health establishment that spent more energy policing Facebook posts than investigating its own product.
Woodcock told them it would come back to bite them. She was right about that, too.
Comments are closed.